Nutritional Intervention Restores Muscle but Not Kidney Phenotypes in Adult Calcineurin Aα Null Mice

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Madsen, Kirsten ^b,c   Reddy, Ramesh N ^b   Price, S Russ ^b   Williams, Clintoria R ^a,b   Gooch, Jennifer L ^a,b  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCINEURIN; CALCINEURIN AALPHA; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; NITROGEN; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DISEASE SEVERITY; FOOD DEPRIVATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY DEVELOPMENT; KIDNEY FUNCTION; MOUSE; MUSCLE CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; ANIMAL; C57BL MOUSE; CALORIC RESTRICTION; GENE DELETION; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SKELETAL MUSCLE; SLOW MUSCLE FIBER; ULTRASTRUCTURE;

ANIMALIA; MUS;

ANIMALS; CALCINEURIN; CALORIC RESTRICTION; GENE DELETION; INSULIN; INSULIN RESISTANCE; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84877003150     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062503     Document Type: Article

References (30)

1. Rusnak F, Mertz P, (2000) Calcineurin: form and function. Physiol Rev 80: 1483-1521.
2. Gooch JL, (2006) An emerging role for calcineurin Aalpha in the development and function of the kidney. Am J Physiol Renal Physiol 290: F769-776.
3. Gooch JL, Toro JJ, Guler RL, Barnes JL, (2004) Calcineurin A-alpha but not A-beta is required for normal kidney development and function. Am J Pathol 165: 1755-1765.
4. Bueno OF, Brandt EB, Rothenberg ME, Molkentin JD, (2002) Defective T cell development and function in calcineurin Abeta-deficient mice. Proceedings of the National Academy of Science 99: 9398-9403.
5. Bueno OF, Wilkins BJ, Tymitz KM, Glascock BJ, Kimball TF, et al. (2002) Impaired cardiac hypertrophic response in calcineurin Abeta-deficient mice. Proceedings of the National Academy of Science 99: 4586-4591.
6. Zhang BW, Zimmer G, Chen J, Ladd D, Li E, et al. (1996) T cell responses in calcineurin A alpha-deficient mice. J Exp Med 183: 413-420.
7. Zhuo M, Zhang W, Son H, Mansuy I, Sobel R, et al. (1999) A selective role of calcineurin Aalpha in synaptic depotentiation in hippocampus. Proceedings of the National Academy of Science 96: 4650-4655.
8. Gooch JL, Roberts BR, Cobbs SL, Tumlin JA, (2007) Loss of the alpha-isoform of calcineurin is sufficient to induce nephrotoxicity and altered expression of transforming growth factor-beta. Transplantation 83: 439-447.
9. Reddy RN, Pena JA, Roberts BR, Williams SR, Price SR, et al. (2011) Rescue of calcineurin Aalpha(-/-) mice reveals a novel role for the alpha isoform in the salivary gland. Am J Pathol 178: 1605-1613.
10. Gooch JL, Barnes JL, Garcia S, Abboud HE, (2003) Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. Am J Physiol Renal Physiol 284: F144-154.
11. Schreuder MF, Nyengaard JR, Remmers F, van Wijk JA, Delemarre-van de Waal HA, (2006) Postnatal food restriction in the rat as a model for a low nephron endowment. Am J Physiol Renal Physiol 291: F1104-1107.
12. Wlodek ME, Westcott K, Siebel AL, Owens JA, Moritz KM, (2008) Growth restriction before or after birth reduces nephron number and increases blood pressure in male rats. Kidney Int 74: 187-195.
13. Ryder JW, Bassel-Duby R, Olson EN, Zierath JR, (2003) Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways. J Biol Chem 278: 44298-44304.
14. Parsons SA, Wilkins BJ, Bueno OF, Molkentin JD, (2003) Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice. Mol Cell Biol 23: 4331-4343.
15. Bailey JL, Wang X, England BK, Price SR, Ding X, et al. (1996) The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97: 1447-1453.
16. Bailey JL, Zheng B, Hu Z, Price SR, Mitch WE, (2006) Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol 17: 1388-1394.
17. Buttini M, Limonta S, Luyten M, Boddeke H, (1993) Differential distribution of calcineurin A alpha isoenzyme mRNA's in rat brain. Naunyn Schmiedebergs Arch Pharmacol 348: 679-683.
18. Kim M, Jung M, Hong SP, Jeon H, Kim MJ, et al. (2010) Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol 19: 501-510.
19. Pena JA, Losi-Sasaki JL, Gooch JL (2009) Loss of Calcineurin Aalpha Alters Keratinocyte Survival and Differentiation. J Invest Dermatol.
20. Gooch JL, Guler RL, Barnes JL, Toro JJ, (2006) Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus. J Cell Sci 119: 2468-2476.
21. Kelly FM, Reddy RN, Roberts BR, Gangappa S, Williams IR, et al. (2009) TGF-beta upregulation drives tertiary lymphoid organ formation and kidney dysfunction in calcineurin A-alpha heterozygous mice. Am J Physiol Renal Physiol 296: F512-520.
22. Puri S, Magenheimer BS, Maser RL, Ryan EM, Zien CA, et al. (2004) Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J Biol Chem 279: 55455-55464.
23. Norwood VF, Morham SG, Smithies O, (2000) Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney International 58: 2291-2300.
24. Komhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, et al. (2000) Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney International 57: 414-422.
25. Parsons SA, Millay DP, Wilkins BJ, Bueno OF, Tsika GL, et al. (2004) Genetic loss of calcineurin blocks mechanical overload-induced skeletal muscle fiber type switching but not hypertrophy. J Biol Chem 279: 26192-26200.
26. Satoh S, Yanagita T, Maruta T, Nemoto T, Yoshikawa N, et al. (2008) Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells. Neuropharmacology 55: 71-79.
27. Sun L, Zhu LL, Zaidi N, Yang G, Moonga BS, et al. (2007) Cellular and molecular consequences of calcineurin A alpha gene deletion. Ann N Y Acad Sci 1116: 216-226.
28. Sun L, Blair HC, Peng Y, Zaidi N, Adebanjo OA, et al. (2005) Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci U S A 102: 17130-17135.
29. Kayyali U, Zhang W, Yee A, Seidman J, Potter H, (1997) Cytoskeletal changes in the brains of mice lacking calcineurin A alpha. Journal Neurochemistry 68: 1668-1678.
30. Pena JA, Losi-Sasaki JL, Gooch JL, (2010) Loss of calcineurin Aalpha alters keratinocyte survival and differentiation. J Invest Dermatol 130: 135-140.